Field Trip Psychedelics Inc. Announces Creation of Field Trip Discovery, The Company's Drug Development Division

Field Trip Psychedelics Inc. Announces Creation of Field Trip Discovery, The Company's Drug Development Division

Press
Apr 9
/

Company also announces appointment of Nathan Bryson as Chief Science Officer and Pharmaceutical Company Executives Dieter Weinand and Helen Boudreau to the Board of Directors Field Trip Psychedelics Inc. (“Field Trip” or the “Company“), the world’s first mental wellness company focused exclusively on psychedelics and psychedelic-enhanced psychotherapy, today announced the creation of Field Trip Discovery, the company’s newly formed drug development division.

Other posts
See all posts
No items found.